Trialynx is a digital protocol authoring and study development platform that accelerates clinical trial startup through insight-driven study design and structured document authoring.

Trialynx (EZ Research Solutions Inc. dba Trialynx) is an enterprise-grade platform transforming the way clinical trials are designed, documented, and executed. Founded by leaders with decades of expertise in clinical trial operations and healthtech innovation, Trialynx enables insight-driven protocol development, structured authoring, and automation to improve compliance and reduce cycle times. The platform digitizes protocols and companion documents, supports collaboration across sponsors, CROs, and sites, and ensures scalability through secure, cloud-based infrastructure. With an active roadmap toward CDISC USDM alignment, Trialynx is shaping the future of digital clinical trial development.